Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #401 to #450.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Radon Recommendations for Workplaces‏‎ (2 revisions)
  2. Cost-benefit analysis‏‎ (2 revisions)
  3. Reference level‏‎ (2 revisions)
  4. Decontamination factor‏‎ (2 revisions)
  5. Remediation‏‎ (2 revisions)
  6. Risk of Exposure to Radon‏‎ (2 revisions)
  7. Dose rate‏‎ (2 revisions)
  8. South Atlantic anomaly‏‎ (2 revisions)
  9. Interventional procedure‏‎ (2 revisions)
  10. Emergency exposure situation‏‎ (2 revisions)
  11. Ethics‏‎ (2 revisions)
  12. Macrophage colony stimulating factor‏‎ (2 revisions)
  13. ALARA‏‎ (2 revisions)
  14. Multiplicative risk projection model‏‎ (2 revisions)
  15. Hierarchical tissues‏‎ (2 revisions)
  16. Area monitoring‏‎ (2 revisions)
  17. Benthic‏‎ (2 revisions)
  18. Bronchial region‏‎ (2 revisions)
  19. Class SR-2 gases‏‎ (2 revisions)
  20. Repopulation‏‎ (2 revisions)
  21. Dichotomous‏‎ (2 revisions)
  22. Routine monitoring‏‎ (2 revisions)
  23. ICRPædia Guide to Radon‏‎ (2 revisions)
  24. Dose rate effectiveness factor‏‎ (2 revisions)
  25. Special (non-routine) monitoring‏‎ (2 revisions)
  26. Emergency plan‏‎ (2 revisions)
  27. Lifetime risk‏‎ (2 revisions)
  28. Threshold dose for tissue reactions‏‎ (2 revisions)
  29. Magnetosphere‏‎ (2 revisions)
  30. Activity‏‎ (2 revisions)
  31. High level waste‏‎ (2 revisions)
  32. Clearance‏‎ (2 revisions)
  33. Radiographer‏‎ (2 revisions)
  34. Deontological Ethics‏‎ (2 revisions)
  35. Representative organism (non-human biota)‏‎ (2 revisions)
  36. Differentiation‏‎ (2 revisions)
  37. ICRPædia Guide to the Basics of Ionising Radiation‏‎ (2 revisions)
  38. Transmission detection system‏‎ (2 revisions)
  39. Multistage tumorigenesis‏‎ (2 revisions)
  40. Non-sphericity parameter‏‎ (2 revisions)
  41. Pharynx‏‎ (2 revisions)
  42. Beta-minus decay‏‎ (2 revisions)
  43. Clearance level‏‎ (2 revisions)
  44. Representative person‏‎ (2 revisions)
  45. Safety‏‎ (2 revisions)
  46. Dose constraint‏‎ (2 revisions)
  47. Early normal tissue responses‏‎ (2 revisions)
  48. Specific effective energy‏‎ (2 revisions)
  49. Limitation of dose‏‎ (2 revisions)
  50. Marrow cellularity‏‎ (1 revision)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)